SSc-ILD ABs & LESSONS:
30% of won't progress.
Triple negatives (ATA, ACA, ARA) wont progress.
Males & diffuse dz > predictive than Abs.
Great read on if Abs are biomarkers to predict Rx effect. https://t.co/YcZt4aAvL0 https://t.co/wOknKRfRHf
Links:
Personalizing Management of Systemic Sclerosis–Associated Interstitial Lung Dis…
https://buff.ly/otQvxpN
08-09-2025
